Mark Jason Heath Ellison, Chief Development Officer: Opiant Pharmaceuticals OPNT Sell · Filed 23/01/05

Trade details

Type: Insider sale
Amount: $36,481.2
Shares · price: 1,806 sh · $20.20 a share
Held after: 19,830 sh
Stock: Opiant Pharmaceuticals OPNT
Person: Mark Jason Heath EllisonChief Development Officer
Trade date: 23/01/05
Filed: 23/01/05
Days to filing: 0 days

Sold 8.3% of holdings

Share of holding sold: 8.3%

Opiant Pharmaceuticals trades, last 26 weeks

What else happened in Opiant Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/06~23/02/04

Mark Jason Heath Ellison's recent trades

Mark Jason Heath EllisonChief Development Officer
SellOpiant Pharmaceuticals
Sell
Opiant Pharmaceuticals
OPNT
$12.4K
610 sh
$12.4K
Filed 23/01/31
Traded 23/01/27
Mark Jason Heath EllisonChief Development Officer
SellOpiant Pharmaceuticals
Sell
Opiant Pharmaceuticals
OPNT
$9,474
469 sh
$9,474
Filed 23/01/09
Traded 23/01/09